Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 37 studies | 37% ± 16% | |
| endothelial cell | 22 studies | 31% ± 12% | |
| macrophage | 19 studies | 29% ± 14% | |
| smooth muscle cell | 17 studies | 36% ± 18% | |
| pericyte | 15 studies | 46% ± 24% | |
| endothelial cell of lymphatic vessel | 11 studies | 31% ± 12% | |
| connective tissue cell | 11 studies | 37% ± 15% | |
| basal cell | 10 studies | 22% ± 5% | |
| endothelial cell of vascular tree | 9 studies | 44% ± 17% | |
| capillary endothelial cell | 9 studies | 23% ± 6% | |
| myeloid cell | 8 studies | 33% ± 11% | |
| myofibroblast cell | 8 studies | 26% ± 11% | |
| vein endothelial cell | 7 studies | 33% ± 13% | |
| endothelial cell of artery | 6 studies | 24% ± 10% | |
| monocyte | 5 studies | 33% ± 16% | |
| secretory cell | 5 studies | 31% ± 18% | |
| adventitial cell | 4 studies | 28% ± 19% | |
| mesothelial cell | 4 studies | 28% ± 9% | |
| classical monocyte | 3 studies | 43% ± 25% | |
| mononuclear phagocyte | 3 studies | 25% ± 5% | |
| mast cell | 3 studies | 18% ± 1% | |
| muscle cell | 3 studies | 32% ± 13% | |
| glial cell | 3 studies | 37% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 91% | 10890.97 | 525 / 578 | 93% | 71.98 | 1069 / 1155 |
| kidney | 96% | 3330.37 | 85 / 89 | 86% | 120.38 | 776 / 901 |
| prostate | 88% | 4403.34 | 215 / 245 | 83% | 71.18 | 416 / 502 |
| breast | 72% | 2187.62 | 329 / 459 | 83% | 46.01 | 927 / 1118 |
| pancreas | 64% | 2102.27 | 209 / 328 | 87% | 62.05 | 154 / 178 |
| adrenal gland | 96% | 3849.36 | 248 / 258 | 54% | 38.42 | 124 / 230 |
| intestine | 82% | 3650.64 | 796 / 966 | 62% | 29.91 | 327 / 527 |
| skin | 62% | 1848.27 | 1117 / 1809 | 78% | 52.86 | 369 / 472 |
| thymus | 76% | 2592.15 | 496 / 653 | 59% | 23.15 | 359 / 605 |
| stomach | 61% | 2996.53 | 219 / 359 | 73% | 36.49 | 210 / 286 |
| esophagus | 64% | 1734.52 | 923 / 1445 | 64% | 38.73 | 118 / 183 |
| ovary | 24% | 420.46 | 44 / 180 | 90% | 67.46 | 387 / 430 |
| uterus | 34% | 692.86 | 57 / 170 | 70% | 44.88 | 322 / 459 |
| bladder | 33% | 3101.14 | 7 / 21 | 68% | 36.10 | 342 / 504 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 69.62 | 28 / 29 |
| liver | 48% | 1040.27 | 109 / 226 | 45% | 28.12 | 182 / 406 |
| heart | 83% | 4518.10 | 718 / 861 | 0% | 0 | 0 / 0 |
| brain | 16% | 421.61 | 419 / 2642 | 66% | 73.78 | 464 / 705 |
| adipose | 77% | 5952.93 | 925 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 73% | 3565.01 | 968 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 27.15 | 31 / 45 |
| spleen | 35% | 556.95 | 85 / 241 | 0% | 0 | 0 / 0 |
| muscle | 12% | 187.28 | 97 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 10% | 1.70 | 8 / 80 |
| peripheral blood | 2% | 32.50 | 17 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019233 | Biological process | sensory perception of pain |
| GO_0043615 | Biological process | astrocyte cell migration |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0050870 | Biological process | positive regulation of T cell activation |
| GO_0001525 | Biological process | angiogenesis |
| GO_0006954 | Biological process | inflammatory response |
| GO_0051770 | Biological process | positive regulation of nitric-oxide synthase biosynthetic process |
| GO_1904783 | Biological process | positive regulation of NMDA glutamate receptor activity |
| GO_0043547 | Biological process | positive regulation of GTPase activity |
| GO_2000502 | Biological process | negative regulation of natural killer cell chemotaxis |
| GO_0009617 | Biological process | response to bacterium |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_1905563 | Biological process | negative regulation of vascular endothelial cell proliferation |
| GO_0007165 | Biological process | signal transduction |
| GO_0071347 | Biological process | cellular response to interleukin-1 |
| GO_0006935 | Biological process | chemotaxis |
| GO_0007155 | Biological process | cell adhesion |
| GO_0007010 | Biological process | cytoskeleton organization |
| GO_0019725 | Biological process | cellular homeostasis |
| GO_0006959 | Biological process | humoral immune response |
| GO_0071356 | Biological process | cellular response to tumor necrosis factor |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0070098 | Biological process | chemokine-mediated signaling pathway |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_2000427 | Biological process | positive regulation of apoptotic cell clearance |
| GO_0048245 | Biological process | eosinophil chemotaxis |
| GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
| GO_0051968 | Biological process | positive regulation of synaptic transmission, glutamatergic |
| GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO_0008360 | Biological process | regulation of cell shape |
| GO_0034351 | Biological process | negative regulation of glial cell apoptotic process |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0002548 | Biological process | monocyte chemotaxis |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0019079 | Biological process | viral genome replication |
| GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
| GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
| GO_2000353 | Biological process | positive regulation of endothelial cell apoptotic process |
| GO_0090280 | Biological process | positive regulation of calcium ion import |
| GO_0048246 | Biological process | macrophage chemotaxis |
| GO_0071346 | Biological process | cellular response to type II interferon |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0035684 | Biological process | helper T cell extravasation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0008009 | Molecular function | chemokine activity |
| GO_0048020 | Molecular function | CCR chemokine receptor binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0031727 | Molecular function | CCR2 chemokine receptor binding |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CCL2 |
| Protein name | C-C motif chemokine ligand 2 (Chemokine (C-C motif) ligand 2, isoform CRA_a) C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2) |
| Synonyms | MCP1 hCG_29298 SCYA2 |
| Description | FUNCTION: Acts as a ligand for C-C chemokine receptor CCR2 . Signals through binding and activation of CCR2 and induces a strong chemotactic response and mobilization of intracellular calcium ions . Exhibits a chemotactic activity for monocytes and basophils but not neutrophils or eosinophils . May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis . . |
| Accessions | ENST00000580907.6 ENST00000225831.4 J3KRT7 P13500 |